Market Reports

2024 Behavioral Health LTC Pharmacy Special Report

In my 2023 Market Outlook Report I wrote about how marginalized patient populations and economic inflation can impact pharmacy values.[...]

More

2023 Compounding Pharmacy M&A Market Update – How USP 800, Semaglutide And Competitive Forces Will Shape The Industry

This year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader[...]

More

2023 LTC Pharmacy Market Update – How Inflation and Marginalized Patients Will Impact Values in The Coming Years

LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed,[...]

More

Healthcare M&A Valuations Expected To Remain Strong In 2023 Despite Uncertainty

The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]

More

How Economic Uncertainty Will Impact Pharmacy Valuations in 2023

The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]

More

2022 Compounding Pharmacy Market Outlook

What’s driving the interest in compounding pharmacy? Disruption, growth and industry architecture. First, acquirers are aggressively seeking to establish boots[...]

More

2022 LTC Pharmacy Market Outlook Report

If you are reading this, you’re likely seeking an answer to the popular question: “How has the pandemic impacted the[...]

More

2021 Compounding Pharmacy Market Outlook

For much of the last decade, compounding pharmacies encountered headwinds in the M&A markets. A combination of high government scrutiny,[...]

More

2020 Fall/Winter LTC Pharmacy Market Update

Long-term care pharmacy faced unprecedented disruptions during 2020. Patients across the entire continuum of care felt an impact in some[...]

More

2020 Specialty and Infusion Pharmacy Outlook

Specialty pharmacy is the fastest growing pharmacy segment and it is estimated that specialty drugs accounted for nearly 70% of[...]

More